[Neurologic cryptococcosis: meningitis of the immunosuppressed patient].
Kallel
K
K
Laboratoire de Parasitologie-Mycologie, Hôpital La Rabta.
Mejri
H
H
Belhadj
S
S
Boussen
N
N
Kilani
B
B
Zouiten
F
F
Ben Abid
H
H
Zribi
A
A
Chaker
E
E
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000382:microbiology; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000150:complications / Q000382:microbiology; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole